Collectively, our mechanistic investigations and clinical data analyses establish that PSMD11 and PSMD14, as critical regulatory subunits of the ubiquitin-proteasome system (UPS), drive oncogenic progression through targeted degradation of tumor-suppressive proteins and stabilization of oncoproteins. Here, PSMD14 is linked to neoplasm.